Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Dale Miles

7PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Apr 16, 2024
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.

Rong Deng, Leonid Gibiansky, Tong Lu

|Mar 19, 2024
Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies.

Hardik Mody, Dhruvitkumar S Sutaria, Dale Miles

|Feb 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.

Sharon P Shriver, Devon Adams, Brittany Avin McKelvey

|Jan 26, 2024
"Digital twins elucidate critical role of T<sub>scm</sub> in clinical persistence of TCR-engineered cell therapy".

Louis R Joslyn, Weize Huang, Dale Miles

|Jul 02, 2023
Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR-T and TCR-T Cell Therapies: An Industry Perspective.

Hardik Mody, Ken Ogasawara, Xu Zhu

|Oct 28, 2021
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study.

Othman Al-Sawaf, Can Zhang, Tong Lu

Pageof 2

Frequent Collaborators

3 joint publications

Tong Lu

1 joint publications

Dan Lu

1 joint publications

Othman Al-Sawaf

1 joint publications

Eugen Tausch

1 joint publications

Sebastian Böttcher

1 joint publications

Ken Ogasawara

1 joint publications

Tong-Yuan Yang

1 joint publications

Nagendra Chemuturi

1 joint publications

Swati Gupta

1 joint publications

Vijay V Upreti

Frequent Collaborators

3 joint publications

Tong Lu

1 joint publications

Dan Lu

1 joint publications

Othman Al-Sawaf

1 joint publications

Eugen Tausch

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

1.2K
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on : Aug 18, 2023

2.6K
Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

10.6K
See more related videos

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

1.2K
Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on : Aug 18, 2023

2.6K
Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of <em>In Vitro</em> Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on : Dec 09, 2015

10.6K
See more related videos